ATE336504T1 - Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung - Google Patents

Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung

Info

Publication number
ATE336504T1
ATE336504T1 AT99924806T AT99924806T ATE336504T1 AT E336504 T1 ATE336504 T1 AT E336504T1 AT 99924806 T AT99924806 T AT 99924806T AT 99924806 T AT99924806 T AT 99924806T AT E336504 T1 ATE336504 T1 AT E336504T1
Authority
AT
Austria
Prior art keywords
mbl
product
virus
purification process
preparation containing
Prior art date
Application number
AT99924806T
Other languages
English (en)
Inventor
Inga Laursen
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of ATE336504T1 publication Critical patent/ATE336504T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
AT99924806T 1998-06-10 1999-06-10 Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung ATE336504T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK79398 1998-06-10
US10100798P 1998-09-18 1998-09-18

Publications (1)

Publication Number Publication Date
ATE336504T1 true ATE336504T1 (de) 2006-09-15

Family

ID=26064673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99924806T ATE336504T1 (de) 1998-06-10 1999-06-10 Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung

Country Status (9)

Country Link
EP (1) EP1084143B1 (de)
AT (1) ATE336504T1 (de)
AU (1) AU764066B2 (de)
CA (1) CA2334696C (de)
DE (1) DE69932817T2 (de)
DK (1) DK1084143T3 (de)
ES (1) ES2272067T3 (de)
NZ (1) NZ509089A (de)
WO (1) WO1999064453A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3990736B2 (ja) 1997-08-21 2007-10-17 タカラバイオ株式会社 制がん剤
DE60030173T2 (de) 1999-05-14 2007-08-23 Steffen Thiel Neue Indikationen für Mannan-binding Lectin (MBL) zur Behandlung von immungeschwächten Patienten
WO2002005833A1 (en) * 2000-07-13 2002-01-24 Natimmune A/S MANNAN-BINDING LECTIN (MBL) TREATMENT OF INFECTIONS IN INDIVIDUALS TREATED WITH TNF-αinhibitors
CN101011573A (zh) 2001-07-23 2007-08-08 纳蒂芒公司 高分子量凝集素的生产
JP4051030B2 (ja) * 2001-08-31 2008-02-20 扶桑薬品工業株式会社 ヒトマンノース結合レクチンの精製方法、ヒトマンノース結合レクチン組成物およびヒトマンノース結合レクチンの医薬用途
AU2003215524A1 (en) * 2002-03-15 2003-09-29 Natimmune A/S Pharmaceutical compositions comprising mannose binding lectin
EP1501537A4 (de) * 2002-04-24 2008-01-16 Queensland Inst Med Res Mannose bindendes lectin und seine verwendungszwecke
GB0222014D0 (en) * 2002-09-23 2002-10-30 Leuven K U Res & Dev Mannan-binding lectin
US20090247454A1 (en) * 2004-09-29 2009-10-01 Mellitus, S.L. Method for detecting a predisposition to develop gestational diabetes mellitus and treatment for this disease
EP1888208B1 (de) * 2004-10-21 2012-11-14 Statens Serum Institut Verfahren mit nanofiltrierung zum erhalnten eines vor infektierenden mitteln sicheren mbl-produkts
WO2007095154A2 (en) * 2006-02-10 2007-08-23 The Brigham And Women's Hospital, Inc. Lectin complement pathway assays and related compositions and methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein

Also Published As

Publication number Publication date
CA2334696C (en) 2014-03-25
CA2334696A1 (en) 1999-12-16
AU764066B2 (en) 2003-08-07
NZ509089A (en) 2002-10-25
DE69932817D1 (de) 2006-09-28
AU4134399A (en) 1999-12-30
DK1084143T3 (da) 2006-12-27
EP1084143B1 (de) 2006-08-16
EP1084143A1 (de) 2001-03-21
WO1999064453A1 (en) 1999-12-16
ES2272067T3 (es) 2007-04-16
DE69932817T2 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
Zocchi et al. A single protein immunologically identified as CD38 displays NAD+ glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
ATE336504T1 (de) Reinigungsverfahren zur herstellng von mannan bindendem lectin (mbl) und mbl enthaltende medizinische zubereitung
US4228154A (en) Purification of plasma albumin by ion exchange chromatography
AU3137699A (en) Novel process for the separation of proteins using a Ca ++ containing eluant
MXPA04006082A (es) Matriz de proteina maleable y usos de la misma.
SE9603068D0 (sv) Process for purifying a protein
TW200505939A (en) Process for production of cyclic peptides
EP0375438A3 (de) Rekombinante DNS-Moleküle, Wirte, Verfahren und proteinartige menschliche Somatomedinträger-Polypeptide
ATE323766T1 (de) Glykosylierte leptinzusammensetzungen und zugehörige verfahren
BR0210386A (pt) Purificação de albumina de soro humano
WO2004042083A3 (en) Nucleic acid ligands and uses therefor
CA2002833A1 (en) Interferon-gamma binding proteins
KR101414897B1 (ko) 다베포에틴 알파의 정제 방법
DE69125381D1 (de) Proteinstruktur des pflanzlichen toxins gelonin
AU2003260045A1 (en) Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
WO2004099233A3 (de) Affinitätsanreicherung von phosphorylierten peptiden und/oder proteinen
HUP9901029A2 (hu) Eljárás rDSPA alfa1 előállítására
EP1475441A3 (de) Spezifische Nukleinsäuren und Polypeptide aus krankheitserregenden Stämmen von Neisseria
WO2005095448A3 (en) Method of synthesizing and purifying dkk proteins and dkk proteins obtained thereby
WO1991015582A3 (en) Purified rap gaps, rap gap sequences, and uses thereof
RU2097049C1 (ru) Способ выделения альфа-фетопротеина из сыворотки крови человека
RU2048521C1 (ru) Способ получения полипептида со свойствами лимфотоксина человека
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
AU5076393A (en) Proteins which regulate the expression of vertebrate MHC class II genes, DNA sequences encoding them and pharmaceutical compositions

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1084143

Country of ref document: EP